[1]
|
Lin, F.-C. and Young, H. (2012) Interferon-gamma, in encyclopedia of signaling molecules. Springer, New York, 966-972.
|
[2]
|
Tabas, I., Williams, K.J. and Boren, J. (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: Update and therapeutic implications. Circulation, 116, 1832-1844.
doi:10.1161/CIRCULATIONAHA.106.676890
|
[3]
|
Hao, X.R., et al. (2009) IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/ STAT signaling pathway-dependent manner. Atherosclerosis, 203, 417-428. doi:10.1016/j.atherosclerosis.2008.07.029
|
[4]
|
Li, N., et al. (2010) ERK is integral to the IFN-gammamediated activation of STAT1, the expression of key genes implicated in atherosclerosis, and the uptake of modified lipoproteins by human macrophages. The Journal of Immunology, 185, 3041-3048.
doi:10.4049/jimmunol.1000993
|
[5]
|
Ahmad, U., et al. (2010) IFN-gamma primes intact human coronary arteries and cultured coronary smooth muscle cells to double-stranded RNAand self-RNAinduced inflammatory responses by upregulating TLR3 and melanoma differentiation-associated gene 5. The Journal of Immunology, 185, 1283-1294.
doi:10.4049/jimmunol.0902283
|
[6]
|
Bergstrom, I., et al. (2012) Persistent accumulation of interferon-gamma-producing CD8+CD56+ T cells in blood from patients with coronary artery disease. Atherosclerosis, 224, 515-520.
doi:10.1016/j.atherosclerosis.2012.07.033
|
[7]
|
Kim, K., et al. (2011) Replicated association of a regulatory polymorphism in the interferon gamma gene with lupus susceptibility. Annals of the Rheumatic Diseases, 70, 1878-1879. doi:10.1136/ard.2010.147249
|
[8]
|
Harigai, M., et al. (2008) Excessive production of IFNgamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand super-family-13B. The Journal of Immunology, 181, 2211-2219.
|
[9]
|
Karonitsch, T., et al. (2009) Activation of the interferongamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells. Arthritis & Rheumatism, 60, 1463-1471.
doi:10.1002/art.24449
|
[10]
|
Lee, S.K., et al. (2012) Interferon-gamma excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity, 37, 880-892.
doi:10.1016/j.immuni.2012.10.010
|
[11]
|
Lee, E., et al. (2012) IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci. Journal of Neuroinflammation, 9, 7.
|
[12]
|
Hindinger, C., et al. (2012) IFN-gamma signaling to astrocytes protects from autoimmune mediated neurological disability. PLoS One, 7, e42088.
doi:10.1371/journal.pone.0042088
|
[13]
|
Lees, J.R. and Cross, A.H. (2007) A little stress is good: IFN-gamma, demyelination, and multiple sclerosis. Journal of Clinical Investigation, 117, 297-299.
doi:10.1172/JCI31254
|
[14]
|
Schurgers, E., Billiau, A. and Matthys, P. (2011) Collagen-induced arthritis as an animal model for rheumatoid arthritis: focus on interferon-gamma. Journal of Interferon & Cytokine Research, 31, 917-926.
doi:10.1089/jir.2011.0056
|
[15]
|
Page, C.E., et al. (2010) Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis. Arthritis Research & Therapy, 12, R49.
|
[16]
|
Karonitsch, T., et al. (2012) Interferon signals and monocytic sensitization of the interferon-gamma signaling pathway in the peripheral blood of patients with rheumatoid arthritis. Arthritis & Rheumatism, 64, 400-408.
doi:10.1002/art.33347
|
[17]
|
Doodes, P.D., et al. (2010) IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis. The Journal of Immunology, 184, 1552-1559.
doi:10.4049/jimmunol.0902907
|
[18]
|
Saha, B., et al. (2009) Gene modulation and immunoregulatory roles of interferon gamma. Cytokine, 50, 1-14.
doi:10.1016/j.cyto.2009.11.021
|
[19]
|
Lipnik, K., et al. (2010) Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice. Molecular Medicine, 16, 177-187.
|
[20]
|
Li, P., et al. (2012) Interferon-gamma induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1). Cancer Letters, 314, 213-222.
doi:10.1016/j.canlet.2011.09.031
|
[21]
|
Schmitt, M.J., et al. (2012) Interferon-gamma-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells. Cell Communication and Signaling, 10, 41.
|
[22]
|
Tate, D.J., et al. (2012) Interferon-gamma-induced nitric oxide inhibits the proliferation of murine renal cell carcinoma cells. International Journal of Biological Sciences, 8, 1109-1120. doi:10.7150/ijbs.4694
|
[23]
|
Mi, Y.Y., et al. (2011) Interferon gamma +874 T/A polymorphism contributes to cancer susceptibility: A meta-analysis based on 17 case-control studies. Molecular Biology Reports, 38, 4461-4467.
doi:10.1007/s11033-010-0575-3
|
[24]
|
Syu, L.J., et al. (2012) Transgenic expression of interferon-gamma in mouse stomach leads to inflammation, metaplasia, and dysplasia. American Journal of Pathology, 181, 2114-2125. doi:10.1016/j.ajpath.2012.08.017
|
[25]
|
Zaidi, M.R., et al. (2011) Interferon-gamma links ultraviolet radiation to melanomagenesis in mice. Nature, 469, 548-553. doi:10.1038/nature09666
|
[26]
|
Berthon, C., et al. (2010) In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors. Cancer Immunology, Immunotherapy, 59, 1839-1849.
doi:10.1007/s00262-010-0909-y
|
[27]
|
Chen, J., et al. (2012) Interferon-gamma-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway. Immunobiology, 217, 385-393.
doi:10.1016/j.imbio.2011.10.016
|
[28]
|
Marsal, J. and Agace, W.W. (2012) Targeting T-cell migration in inflammatory bowel disease. Journal of Internal Medicine, 272, 411-429.
doi:10.1111/j.1365-2796.2012.02588.x
|
[29]
|
Nava, P., et al. (2010) Interferon-gamma regulates intestinal epithelial homeostasis through converging betacatenin signaling pathways. Immunity, 32, 392-402.
doi:10.1016/j.immuni.2010.03.001
|
[30]
|
Capaldo, C.T., et al. (2012) IFN-gamma and TNF-alphainduced GBP-1 inhibits epithelial cell proliferation through suppression of beta-catenin/TCF signaling. Mucosal Immunology, 5, 681-690.
doi:10.1038/mi.2012.41
|
[31]
|
Colgan, S.P. and Taylor, C.T. (2010) Hypoxia: An alarm signal during intestinal inflammation. Nature Reviews Gastroenterology & Hepatology, 7, 281-287.
doi:10.1038/nrgastro.2010.39
|
[32]
|
Glover, L.E., et al. (2011) IFN-gamma attenuates hypoxia-inducible factor (HIF) activity in intestinal epithetlial cells through transcriptional repression of HIF-1beta. The Journal of Immunology, 186, 1790-1798.
doi:10.4049/jimmunol.1001442
|
[33]
|
Ahern, P.P., et al. (2010) Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity, 33, 279-288. doi:10.1016/j.immuni.2010.08.010
|
[34]
|
Sheikh, S.Z., et al. (2010) Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis. The Journal of Immunology, 184, 4069-4073. doi:10.4049/jimmunol.0903600
|
[35]
|
Jin, Y., et al. (2012) IL-17/IFN-gamma interactions regulate intestinal inflammation in TNBS-induced acute colitis. Journal of Interferon & Cytokine Research, 32, 548-556. doi:10.1089/jir.2012.0030
|
[36]
|
Ito, R., et al. (2006) Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clinical & Experimental Immunology, 146, 330338. doi:10.1111/j.1365-2249.2006.03214.x
|
[37]
|
Glass, C.K., et al. (2010) Mechanisms underlying inflammation in neurodegeneration. Cell, 140, 918-934.
doi:10.1016/j.cell.2010.02.016
|
[38]
|
Jung, J.S., Kim, D.H. and Kim, H.S. (2010) Ginsenoside Rh1 suppressesinducible nitric oxide synthase gene expression in IFN-gamma-stimulated microglia via modulation of JAK/STAT and ERK signaling pathways. Biochemical and Biophysical Research Communications, 397, 323-328. doi:10.1016/j.bbrc.2010.05.117
|
[39]
|
Chakrabarty, P., et al. (2011) Interferon-gamma induces progressive nigrostriatal degeneration and basal ganglia calcification. Nature Neuroscience, 14, 694-696.
|
[40]
|
Barcia, C., et al. (2012) IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson’s disease. Cell Death & Disease, 2, e142.
|
[41]
|
Browne, T.C., et al. (2013) IFN-gamma production by amyloid beta-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer’s disease. The Journal of Immunology, 190, 2241-2251. doi:10.4049/jimmunol.1200947
|
[42]
|
Ryu, H.J., et al. (2010) The protective effects of interleukin-18 and interferon-gamma on neuronal damages in the rat hippocampus following status epilepticus. Neuroscience, 170, 711-721.
doi:10.1016/j.neuroscience.2010.07.048
|
[43]
|
Victorio, S.C., Havton, L.A. and Oliveira, A.L. (2010) Absence of IFNgamma expression induces neuronal degeneration in the spinal cord of adult mice. Journal of Neuroinflammation, 7, 77.
|
[44]
|
Chakrabarty, P., et al. (2010) IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice. The Journal of Immunology, 184, 5333-5343.
doi:10.4049/jimmunol.0903382
|
[45]
|
De Bruin, A.M., et al. (2013) Interferon-gamma impairs proliferation of hematopoietic stem cells in mice. Blood, 121, 3578-3585. doi:10.1182/blood-2012-05-432906
|
[46]
|
Baldridge, M.T., et al. (2010) Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature, 465, 793-797.
|
[47]
|
MacNamara, K.C., et al. (2011) Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-gamma signaling. The Journal of Immunology, 186, 1032-1043.
doi:10.4049/jimmunol.1001893
|
[48]
|
Zahir, T., et al. (2009) Neural stem/progenitor cells differentiate in vitro to neurons by the combined action of dibutyryl cAMP and interferon-gamma. Stem Cells and Development, 18, 1423-1432. doi:10.1089/scd.2008.0412
|
[49]
|
Tanner, D.C., Cherry, J.D. and Mayer-Proschel, M. (2011) Oligodendrocyte progenitors reversibly exit the cell cycle and give rise to astrocytes in response to interferongamma. The Journal of Neuroscience, 31, 6235-6246.
doi:10.1523/JNEUROSCI.5905-10.2011
|
[50]
|
Duque, G., et al. (2009) Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells, 27, 550-558.
doi:10.1634/stemcells.2008-0886
|